subscribeSubscribe
From injections to pills: FDA approves first oral GLP-1 for type 2 diabetes

From injections to pills: FDA approves first oral GLP-1 for type 2 diabetes
Allie Nawrat PHARMACEUTICAL TECHNOLOGY
09 Oct 2019
Share Share
Eli Lilly picks up an oral GLP-1 diabetes drug from Roche sub for $50M

Eli Lilly picks up an oral GLP-1 diabetes drug from Roche sub for $50M
John Carroll ENDPTS
27 Sep 2018
Share Share
ADA: Trulicity bests Victoza, Bydureon in real-world study

ADA: Trulicity bests Victoza, Bydureon in real-world study
Eric Sagonowsky FIERCE PHARMA
25 Jun 2018
Share Share
AstraZeneca’s once-weekly diabetes drug wins expanded FDA approval

AstraZeneca’s once-weekly diabetes drug wins expanded FDA approval
Sarah Faulkner DRUGDELIVERY
03 Apr 2018
Share Share
Novo gets FDA blessing for Type 2 diabetes drug Ozempic

Novo gets FDA blessing for Type 2 diabetes drug Ozempic
E. Sagonowsky FIERCE PHARMA
06 Dec 2017
Share Share
AZ GLP-1 trailer Bydureon gets a facelift with BCise approval

AZ GLP-1 trailer Bydureon gets a facelift with BCise approval
Carly Helfand FIERCE PHARMA
23 Oct 2017
Share Share
AstraZeneca receives US FDA approval for once-weekly Bydureon BCise injectable

AstraZeneca receives US FDA approval for once-weekly Bydureon BCise injectable
PHARMABIZ
23 Oct 2017
Share Share
Why did AstraZeneca`s Bydureon fail to cut CV risks?

Why did AstraZeneca`s Bydureon fail to cut CV risks?
Carly Helfand FIERCE PHARMA
14 Sep 2017
Share Share
AstraZeneca puts Brilinta, Bydureon on pay-for-performance bandwagon

AstraZeneca puts Brilinta, Bydureon on pay-for-performance bandwagon
Carly Helfand FIERCE PHARMA
31 May 2017
Share Share
AstraZeneca asthma shot hits goal but diabetes drug lags rival

AstraZeneca asthma shot hits goal but diabetes drug lags rival
Ben Hirschler REUTERS
23 May 2017
Share Share